Catheter ablation appears better than drug therapy for treating atrial fibrillation (AF) in racial and ethnic minorities, according to a new look at CABANA trial data. CABANA, which was undertaken to compare catheter ablation and rate-control or rhythm-control drug therapy for AF, concluded there was no significant difference between the two strategies in improving the